N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Senior Scientist - Chemical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USANo salary listed

About the Job

Requirements

  • A PhD with 2–7 years of experience or an MS with 5+ years of experience, in Organic Chemistry, Chemical Engineering, Pharmaceutical Chemistry, Pharmaceutics, Pharmaceutical Science, or a related scientific discipline.
  • Experience leveraging U.S. and international CROs/CMOs for the manufacture of regulatory starting materials and drug substance to meet aggressive timelines.
  • Strong working knowledge of synthetic organic chemistry and the ability to apply it to route development and rapid synthetic triage.
  • Experience analyzing experimental and analytical data.
  • Ability to identify and resolve critical issues.
  • Experience implementing technical, strategic, and operational plans.
  • Excellent written and verbal communication skills and interpersonal and management skills to collaborate with and direct the work of others on assigned projects, including internal teams and external collaborators.

Responsibilities

  • Own chemical development activities across the portfolio, including process development and manufacture of regulatory starting materials and support production of drug substance for clinical trial materials, focusing on early development.
  • Scout routes for preclinical and clinical candidates.
  • Support the preclinical research team by developing robust and scalable processes for initial scale-up for animal studies.
  • Work in the lab up to 50% of the time to support early route scouting and discovery scale-up toward CMC transition.
  • Author technology transfer documents and work with CROs/CDMOs to reproduce chemistry effectively and efficiently at various sites.
  • Support regulatory starting material and drug substance manufacturing activities at CRO/CDMO sites, including scaling up candidate compounds to support candidate selection during drug discovery.
  • Support phase-appropriate process characterization, identify critical quality attributes, and implement controls, including selecting and justifying regulatory starting materials, to ensure CROs and CMOs use systems and processes compliant with relevant regulatory standards and to ensure consistent drug substance quality.
  • Prepare and/or review CMC sections of INDs, CTAs, NDAs, MAAs, and other regulatory submissions.
  • Travel up to 10%.

Desired Qualifications

  • 2–5 years of relevant experience in a pharmaceutical or biotechnology CMC/cGMP environment.
  • Experience with payload linker development for antibody-drug conjugates.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs